Henry Schein (HSIC) Banks on Strategic Buyouts Amid Macro Issues
Henry Schein Is Maintained at Outperform by Barrington Research
Henry Schein Is Maintained at Outperform by Barrington Research
Breaking Down Henry Schein: 4 Analysts Share Their Views
Ratings for Henry Schein (NASDAQ:HSIC) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The table below summarizes their recent ratings, showc
Barrington Research Maintains Outperform on Henry Schein, Maintains $92 Price Target
Barrington Research analyst Michael Petusky maintains Henry Schein (NASDAQ:HSIC) with a Outperform and maintains $92 price target.
Barrington Maintains Henry Schein(HSIC.US) With Buy Rating, Maintains Target Price $92
Barrington analyst Michael Petusky maintains $Henry Schein(HSIC.US)$ with a buy rating, and maintains the target price at $92.According to TipRanks data, the analyst has a success rate of 49.0% and a
Maintained OUTPERFORM Rating for Henry Schein Amidst Recovery and Growth Prospects
Is Henry Schein, Inc.'s (NASDAQ:HSIC) Stock Price Struggling As A Result Of Its Mixed Financials?
With its stock down 15% over the past three months, it is easy to disregard Henry Schein (NASDAQ:HSIC). We, however decided to study the company's financials to determine if they have got anything t
ZimVie May Be Worth $25-$29 a Share in Takeover -analyst
Looking Into Henry Schein's Recent Short Interest
Henry Schein's (NYSE:HSIC) short percent of float has risen 14.11% since its last report. The company recently reported that it has 6.06 million shares sold short, which is 5.42% of all regular shares
Henry Schein Says Its Unit Biohorizons Released Tapered Pro Conical, Its First Dental Implant With A Deep Conical Connection
Tapered Pro Conical leverages the successful macro design of Tapered Pro with the proven and patented CONELOG connection to provide clinicians with a predictable solution for immediate treatment, from
BioHorizons Enhances Tapered Pro Portfolio With Tapered Pro Conical
New Implant Connection Helps Enhance Surgical Efficiency to Deliver Immediate Implant Procedures BioHorizons released Tapered Pro Conical, its first dental implant with a deep conical connection. This new implant
Express News | Henry Schein Inc : Evercore ISI Cuts Target Price to $75 From $79
Henry Schein Price Target Maintained With a $86.00/Share by Piper Sandler
Henry Schein Price Target Maintained With a $86.00/Share by Piper Sandler
Piper Sandler Reiterates Overweight on Henry Schein, Maintains $86 Price Target
Piper Sandler analyst Jason Bednar reiterates Henry Schein with a Overweight and maintains $86 price target.
Henry Schein Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/21/2024 29.32% Piper Sandler $86 → $86 Reiterates Overweight → Overweight 05/08/2024 38.35% Barrington
Piper Sandler Maintains Henry Schein(HSIC.US) With Buy Rating, Maintains Target Price $86
Piper Sandler analyst Jason Bednar maintains $Henry Schein(HSIC.US)$ with a buy rating, and maintains the target price at $86.According to TipRanks data, the analyst has a success rate of 36.9% and a
Here's Why Henry Schein (NASDAQ:HSIC) Has A Meaningful Debt Burden
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like
Clinician's Choice Launches MPa Universal
LONDON, Ontario--(BUSINESS WIRE)--Clinician's Choice is expanding their MPa family of adhesives with MPa Universal. MPa Universal offers a cost-effective and reliable solution for both direct and indi
S.M.I.L.E. Healthcare Pathway Program Announces Strategic Expansion With Leading Dental Industry Partners
The S.M.I.L.E. (Student Mentoring with Immersive Learning and Enrichment) Healthcare Pathway Program, a leader in advancing oral health equity, is pleased to announce the addition of several prominent organizations as
Insider Sale: Sr. VP & Chief Legal Officer Walter Siegel Sells Shares of Henry Schein Inc (HSIC)